PubMed

Essential thrombocythemia.

Brière JB.

Orphanet J Rare Dis. 2007 Jan 8;2:3. Review.PMID: 17210076 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.

Bellucci S, Michiels JJ.

Semin Thromb Hemost. 2006 Jun;32(4 Pt 2):381-98. Review.PMID: 16810614 [PubMed - indexed for MEDLINE]Related articles

Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.

Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W.

Semin Thromb Hemost. 2006 Apr;32(3):174-207. Review.PMID: 16673274 [PubMed - indexed for MEDLINE]Related articles

[Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome]

Brière J.

Bull Acad Natl Med. 2007 Mar;191(3):535-48. Review. French. PMID: 18072652 [PubMed - indexed for MEDLINE]Related articles

Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.

Michiels JJ, Kutti J, Stark P, Bazzan M, Gugliotta L, Marchioli R, Griesshammer M, van Genderen PJ, Brière J, Kiladjian JJ, Barbui T, Finazzi G, Berlin NI, Pearson TC, Green AC, Fruchtmann SM, Silver RT, Hansmann E, Wehmeier A, Lengfelder E, Landolfi R, Kvasnicka HM, Hasselbalch H, Cervantes F, Thiele J, et al.

Neth J Med. 1999 Feb;54(2):46-62. Review.PMID: 10079679 [PubMed - indexed for MEDLINE]Related articles

The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.

Michiels JJ, De Raeve H, Berneman Z, Van Bockstaele D, Hebeda K, Lam K, Schroyens W.

Semin Thromb Hemost. 2006 Jun;32(4 Pt 2):307-40. Review.PMID: 16810609 [PubMed - indexed for MEDLINE]Related articles

Megakaryopoiesis and platelet function in polycythemia vera and essential thrombocythemia patients with JAK2 V617F mutation.

Hattori N, Fukuchi K, Nakashima H, Maeda T, Adachi D, Saito B, Yanagisawa K, Matsuda I, Nakamaki T, Gomi K, Tomoyasu S.

Int J Hematol. 2008 Sep;88(2):181-8. Epub 2008 Jul 10.PMID: 18612778 [PubMed - indexed for MEDLINE]Related articles

Essential thrombocythemia in young adults: major thrombotic complications and complications during pregnancy--a follow-up study in 68 patients.

Randi ML, Rossi C, Fabris F, Girolami A.

Clin Appl Thromb Hemost. 2000 Jan;6(1):31-5.PMID: 10726046 [PubMed - indexed for MEDLINE]Related articles

Essential thrombocythemia.

Finazzi G, Harrison C.

Semin Hematol. 2005 Oct;42(4):230-8. Review.PMID: 16210036 [PubMed - indexed for MEDLINE]Related articles

Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.

Michiels JJ, Berneman Z, Schroyens W, Koudstaal PJ, Lindemans J, Neumann HA, van Vliet HH.

Platelets. 2006 Dec;17(8):528-44.PMID: 17127481 [PubMed - indexed for MEDLINE]Related articles

Chronic myeloproliferative disorders.

Spivak JL, Barosi G, Tognoni G, Barbui T, Finazzi G, Marchioli R, Marchetti M.

Hematology Am Soc Hematol Educ Program. 2003:200-24. Review.PMID: 14633783 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term management of thrombocytosis in essential thrombocythaemia.

Birgegård G.

Ann Hematol. 2009 Jan;88(1):1-10. Epub 2008 Jul 16. Review.PMID: 18629498 [PubMed - indexed for MEDLINE]Related articles

The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.

Michiels JJ, Berneman Z, Schroyens W, Finazzi G, Budde U, van Vliet HH.

Semin Thromb Hemost. 2006 Sep;32(6):589-604. Review.PMID: 16977569 [PubMed - indexed for MEDLINE]Related articles

Aspirin and platelet-lowering agents for the prevention of vascular complications in essential thrombocythemia.

Michiels JJ.

Clin Appl Thromb Hemost. 1999 Oct;5(4):247-51. Review.PMID: 10726022 [PubMed - indexed for MEDLINE]Related articles

Anagrelide: analysis of long-term efficacy, safety and leukemogenic potential in myeloproliferative disorders.

Fruchtman SM, Petitt RM, Gilbert HS, Fiddler G, Lyne A; Anagrelide Study Group.

Leuk Res. 2005 May;29(5):481-91. Epub 2005 Jan 21.PMID: 15755500 [PubMed - indexed for MEDLINE]Related articles

[Primary thrombocythemia: diagnosis and therapy]

Petrides PE.

Med Klin (Munich). 2006 Aug 15;101(8):624-34. Review. German. PMID: 16896569 [PubMed - indexed for MEDLINE]Related articles

Pathogenetic role of JAK2 V617F mutation in chronic myeloproliferative disorders.

Hsu HC.

J Chin Med Assoc. 2007 Mar;70(3):89-93. Review.PMID: 17389152 [PubMed - indexed for MEDLINE]Related articlesFree article

A clinical update in polycythemia vera and essential thrombocythemia.

Tefferi A, Solberg LA, Silverstein MN.

Am J Med. 2000 Aug 1;109(2):141-9. Review.PMID: 10967156 [PubMed - indexed for MEDLINE]Related articles

Management of patients with essential thrombocythemia: current concepts and perspectives.

Briere J, Guilmin F.

Pathol Biol (Paris). 2001 Mar;49(2):178-83. Review.PMID: 11317966 [PubMed - indexed for MEDLINE]Related articles

The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis.

Ruggeri M, Tosetto A, Frezzato M, Rodeghiero F.

Ann Intern Med. 2003 Sep 16;139(6):470-5.PMID: 13679323 [PubMed - indexed for MEDLINE]Related articlesFree article